Czech National Bank Boosts Position in Danaher Corporation $DHR

Key Points

• The Czech National Bank increased its stake in Danaher Corporation by 5.9% during the second quarter, bringing its holdings to $30.76 million worth of shares.
• Danaher reported quarterly earnings of $1.80 per share, exceeding estimates, with a revenue of $5.94 billion and a year-over-year revenue increase of 3.4%.
• The company announced a quarterly dividend of $0.32 per share, payable on October 31st, which results in an annualized yield of 0.7%.

Czech National Bank increased its stake in Danaher Corporation (NYSE:DHR - Free Report) by 5.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 155,692 shares of the conglomerate's stock after buying an additional 8,730 shares during the period. Czech National Bank's holdings in Danaher were worth $30,755,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC purchased a new position in Danaher in the 4th quarter worth about $27,000. GHP Investment Advisors Inc. increased its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC increased its stake in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the 1st quarter worth about $31,000. Finally, Dunhill Financial LLC increased its stake in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Down 1.0%

Shares of NYSE DHR opened at $188.24 on Tuesday. The company's 50-day simple moving average is $200.98 and its 200-day simple moving average is $198.64. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The firm has a market cap of $134.79 billion, a price-to-earnings ratio of 40.05, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's dividend payout ratio is presently 27.23%.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on DHR shares. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Guggenheim reissued a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Robert W. Baird raised their target price on shares of Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research report on Friday, July 18th. Finally, Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a research report on Friday, July 11th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.